Enrollment Complete in ARO-APOC3 Trial for Familial Chylomicronemia Syndrome

  Right now, there are insufficient treatment options for familial chylomicronemia syndrome (FCS). Unfortunately, this means that individuals living with this rare genetic disease are left without much assistance. The…

Continue Reading Enrollment Complete in ARO-APOC3 Trial for Familial Chylomicronemia Syndrome